Menarini Industrie Farmaceutiche Riunite: Menarini Group Presents Updated Data from ELECTRA and ELEVATE Combination Studies of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2024 Annual Meeting finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Pharmaceutical industry spring summit: Greece at the heart of pharmaceutical innovation en.protothema.gr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from en.protothema.gr Daily Mail and Mail on Sunday newspapers.
Towards a Future with More Cancer Survivors in Europe euractiv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from euractiv.com Daily Mail and Mail on Sunday newspapers.
Insilico Medicine, backed by blue-chip investors like Warburg Pincus and Qiming Venture Partners, has 17 preclinical drug candidates so far and earlier this month signed a $500 million licensing deal with Italy’s Menarini.